Lumos Pharma
- Home
- Companies
- Lumos Pharma
- Articles
1 Article found
Lumos Pharma articles
Abstract
Abstract Title: “LUM-201 Elicits Greater GH Response than Standard GH Secretagogues in Pediatric Growth Hormone Deficiency “Presentation Type: Oral Science Type and Topic: Clinical Trial Introduction: LUM-201 (ibutamoren, formerly MK-0677) is an orally administered GH-secretagogue that stimulates the GH secretagogue receptor (GHSR1a) in the hypothalamus and pituitary. LUM-201 is in development for long-term use in a subset of PGHD patients with moder
Mar. 19, 2021
George Bright;Roy Smith;Michael O. Thorner
